Valence8 Us LP Novo Nordisk A S Transaction History
Valence8 Us LP
- $241 Billion
- Q3 2024
A detailed history of Valence8 Us LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Valence8 Us LP holds 3,900 shares of NVO stock, worth $421,239. This represents 0.19% of its overall portfolio holdings.
Number of Shares
3,900Holding current value
$421,239% of portfolio
0.19%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVO
# of Institutions
1,956Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.18 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.55 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.55 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.44 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.32 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $244B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...